Multi‐omic profiling reveals an RNA processing rheostat that predisposes to prostate cancer
Open Access
- 24 April 2023
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 15 (6) , e17463
Abstract
Prostate cancer is the most commonly diagnosed malignancy and the third leading cause of cancer deaths. GWAS have identified variants associated with prostate cancer susceptibility; however, mechanistic and functional validation of these mutations is lacking. We used CRISPR‐Cas9 genome editing to introduce a missense variant identified in the ELAC2 gene, which encodes a dually localised nuclear and mitochondrial RNA processing enzyme, into the mouse Elac2 gene as well as to generate a prostate‐specific knockout of Elac2 . These mutations caused enlargement and inflammation of the prostate and nodule formation. The Elac2 variant or knockout mice on the background of the transgenic adenocarcinoma of the mouse prostate (TRAMP) model show that Elac2 mutation with a secondary genetic insult exacerbated the onset and progression of prostate cancer. Multiomic profiling revealed defects in energy metabolism that activated proinflammatory and tumorigenic pathways as a consequence of impaired noncoding RNA processing and reduced protein synthesis. Our physiologically relevant models show that the ELAC2 variant is a predisposing factor for prostate cancer and identify changes that underlie the pathogenesis of this cancer.Keywords
Funding Information
- Cancer Council Western Australia
- Cooperative Research Centres, Australian Government Department of Industry
- Australian Research Council
- National Health and Medical Research Council
- University of Western Australia
This publication has 114 references indexed in Scilit:
- p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epitheliaProceedings of the National Academy of Sciences, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal cladesNucleic Acids Research, 2011
- REVIGO Summarizes and Visualizes Long Lists of Gene Ontology TermsPLOS ONE, 2011
- Localization of Human RNase Z Isoforms: Dual Nuclear/Mitochondrial Targeting of the ELAC2 Gene Product by Alternative Translation InitiationPLOS ONE, 2011
- Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder populationThe Prostate, 2010
- ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case–control studiesProstate Cancer and Prostatic Diseases, 2010
- RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing EnzymeCell, 2008
- Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse modelJournal of Clinical Investigation, 2008
- The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene listsGenome Biology, 2007